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Abstract
Background: Trauma is a leading cause of morbidity and mortality worldwide with about 5.8 million deaths
globally and the leading cause of death in those aged 45 and younger. The pre-hospital phase of traumatic injury is
particularly important as care received during this phase has effects on survival. The need for high quality clinical
trials in this area has been recognised for several years as a key priority to improve the evidence base and,
ultimately, clinical care in prehospital trauma. We aimed to systematically map the existing evidence base for pre-
hospital trauma trials, to identify knowledge gaps and inform decisions about the future research agenda.
Methods: A systematic mapping review was conducted first employing a search of key databases (MEDLINE, CINA
HL, EMBASE, and Cochrane Library from inception to March 23rd 2020) to identify randomised controlled trials
within the pre-hospital trauma and injury setting. The evidence ‘map’ identified and described the characteristics of
included studies and compared these studies against existing priorities for research. Narrative description of studies
informed by analysis of relevant data using descriptive statistics was completed.
Results: Twenty-three eligible studies, including 10,405 participants across 14 countries, were identified and
included in the systematic map. No clear temporal or geographical trends in publications were identified. Studies
were categorised into six broad categories based on intervention type with evaluations of fluid therapy and
analgesia making up 60% of the included trials. Overall, studies were heterogenous with regard to individual
interventions within categories and outcomes reported. There was poor reporting across several studies. No studies
reported patient involvement in the design or conduct of the trials.
Conclusion: This mapping review has highlighted that evidence from trials in prehospital trauma is sparse and
where trials have been completed, the reporting is generally poor and study designs sub-optimal. There is a
continued need, and significant scope, for improvement in a setting where high quality evidence has great
potential to make a demonstrable impact on care and outcomes.
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Background
Trauma is a leading cause of morbidity and mortality
worldwide with road traffic injuries and self-inflicted injur-
ies being the most common causes of trauma [1]. Accord-
ing to the World Health Organisation (WHO), injuries
cause 32% more deaths than malaria, tuberculosis, and
HIV/AIDS combined, with about 5.8 million deaths
globally being caused by injuries [2]. In the UK and the US
major trauma is the leading cause of death in those under
45 years and a significant cause of short and long-term
morbidity [3, 4]. The National Audit Office estimate that
major trauma costs the NHS between £0.3 and £0.4 billion
a year in immediate treatment with an annual lost eco-
nomic output between £3.3 and £3.7 billion [3, 5]. Within a
major trauma setting, the quality of care delivered to
patients in a pre-hospital setting has a critical impact on
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their chances of survival and future quality of life [6, 7].
Despite the significant economic and health burdens associ-
ated with pre-hospital trauma there are still many un-
answered questions about how to treat these patients
effectively [8, 9].
Randomised controlled trials (RCTs) are key to
informing best clinical practice. RCTs are a reliable way
of assessing the effectiveness (both clinical and cost) of
different healthcare interventions but are rare in pre-
hospital trauma where studies are often based on regis-
try data using prospective before-and-after designs [8].
This is partly because there are a number of significant
logistical and methodological challenges to conducting
RCTs in a pre-hospital trauma setting [10]. The major
difficulties in conducting RCTs in pre-hospital trauma
lie in various aspects of trial design and conduct. For
example, a key consideration for trial design can relate
to the sometimes small (and specialised) numbers of
potentially eligible patients where a standard design
might be difficult and therefore adaptive trial designs
may be more appropriate [11]. From a conduct per-
spective, the importance of timeliness with regard to
accessing the patient, randomisation (often remotely)
and delivery of the intervention is also key. The broader
ethical considerations relating to recruitment, capacity
and consent under the challenging circumstances sur-
rounding major trauma also need to be considered [12].
Futhermore, the complex nature of traumatic injuries
can result in patients receiving multiple interventions
(that may not be standardised in or between trauma
centres) both pre and within hospital, making it very
difficult to disentangle intervention effect on outcomes
such as mortality [8].
Whilst RCTs in prehospital trauma care are challen-
ging to design and deliver they are not impossible. Two
existing reviews have collated the literature on prehospi-
tal trauma trials [13, 14]. One of these reviews, which
aimed to develop a register of prehospital trauma RCTs,
was published in 2002 and identified 24 studies pub-
lished over 34 years. However, some of the interventions
included are no longer in standard use and the informa-
tion reported was limited (to intervention type, number
of patients, and the adequacy of allocation concealment)
[13]. The second review (conducted as part of a larger
project to inform a trial) also identified a paucity of pre-
hospital trauma RCTs, identifying 15 trials in 15 years,
but was focused on interventions delivered by land-
based ambulance services [14]. Given the tight focus of
this previous work (e.g. minimal trial features reported,
focused on land-based retrieval) an up to date review of
published pre-hospital trauma trials is needed.
Systematic mapping reviews are a form of evidence
synthesis that aim to conduct a systematic search of a
broad and/or heterogeneous evidence base in order to
plan or prioritise future evaluative syntheses and identify
gaps in knowledge to inform future research needs [15].
This systematic mapping review aimed to identify RCTs
in pre-hospital trauma settings and characterize the key
components of these trials in terms of trial design and
conduct and compare these trials to existing priorities
for research in prehospital trauma. This review provides
evidence to determine what research priorities remain
unanswered and explore key considerations for future
trial design and delivery.
Methods
Search strategy
To identify relevant literature for this review, four data-
bases (MEDLINE, CINAHL, EMBASE, and Cochrane
Library) were searched from inception to 23rd of March
2020. Title and abstract screening were limited to stud-
ies identified from 2000 onwards due to the identifica-
tion of existing reviews that included the pre-2000
literature [13]. The key search words within titles and
abstracts for identifying relevant studies were ‘prehospi-
tal’ or ‘pre-hospital’, EMS, HEMS, emergency, trauma*,
injury*, trial and study. The strategy was largely
informed by a previous scoping review and further
developed in consultation with an Information Scientist
and with input from a pre-hospital care clinician (RL)
[14]. A full search strategy is available in Appendix.
Eligibility criteria
Randomised controlled trials within the pre-hospital
trauma and injury setting were considered eligible. Inter-
ventions had to target patients (rather than the medical
personnel) and had to be delivered in the pre-hospital
setting (at least partially i.e. intervention started in pre-
hospital setting). Any comparators, any treatment dur-
ation and follow up periods were considered. Study out-
comes had to be clinical or health related. Studies were
excluded based on the following criteria: non-trauma
pre-hospital trials (e.g. management of stroke or out of
hospital medical cardiac arrest, etc.), intervention not
delivered in a pre-hospital setting, intervention does not
target the index trauma injury, studies conducted in
low-middle income countries (as there are additional is-
sues affecting the design and delivery of RCTS in these
countries e.g. less developed pre-hospital services that
are out with the scope of this protocol), studies pub-
lished before the year 2000, and studies where no full re-
port was available in English. Hypothetical trials and
trials including healthy volunteers were also excluded.
Eligibility screening process
Tiles and abstracts identified through the search were
independently assessed against the eligibility criteria by
two reviewers (MB and KG, each screening 50% of total)
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with a third reviewer (MC) screening a random 10% of
the overall search output. Potentially eligible abstracts
were further reviewed by the clinician reviewer (RL).
Any disagreements regarding eligibility were discussed
between the team to establish consensus. Full text arti-
cles were obtained for those studies that on initial
screening were considered potentially relevant and were
further assessed for inclusion. All full text papers were
assessed independently by two reviewers (MB and KG)
with disagreements resolved between the review team.
Reference lists of all included studies were examined for
further relevant studies.
Data extraction
A data extraction form was developed by the review
team and piloted on three eligible studies. Information
from all included studies was extracted by one reviewer
(MB) with a random sample of 25% of studies assessed
independently by two other reviewers (KG and MC).
The following summary data were extracted and sum-
marised from each study; study setting; sample size, type
of trauma, participant characteristics; intervention (i.e.
content and delivery), comparator, outcome (i.e. primary
outcome, measurement, timing); methodological consid-
erations (including trial design including whether adap-
tive, number of arms, method of randomisation, consent
process, and whether the trial was stopped early); overall
result; and patient and public involvement.
Data analysis
Data from the studies included in this review were ana-
lysed descriptively with descriptive statistics used for
reporting frequencies where appropriate. Temporal and
geographical data were represented in visual graphs to il-
lustrate trends. All other data were presented in tabular
form. Intervention category labels were agreed upon be-
tween all reviewers and informed by a previous review of
pre-hospital trauma trials that categorised studies by
intervention type [13]. Decisions relating to whether in-
cluded trials were considered as adaptive designs was
based on the information provided showing a pre-
planned change that an adaptive design might permit as
per guidance [16]. Meta-analysis was not appropriate
due to the heterogeneity of the studies with regard to in-
terventions and outcomes.
Quality appraisal
Risk of bias was assessed using an abridged version of
the Cochrane Risk of Bias Tool (version 1). Risk of bias
was assessed using questions related to random
sequence generation, allocation concealment, blinding of
participants and personnel, and blinding of outcome
assessment. The risk of bias was categorised as either
‘low’, ‘high’ or ‘unclear’. The assessment was carried out
by one reviewer (MB) with a 25% random sample inde-
pendently assessed by two other reviewers (KG and
MC).
Results
After removing duplicates, 4164 unique references were
identified from January 2000 to March 2020. The major-
ity of these (n = 4097) were excluded as their title or
abstract did not meet the eligibility criteria, which pro-
vided 67 articles for full text screening (see Fig. 1). A
further 44 articles were excluded at full text screening
resulting in a total of 23 studies being eligible and
included in the mapping review [17–39].
Study characteristics
The general study characteristics of all 23 studies can be
seen in Table 1. There were slight differences in num-
bers of publication by year between 2000 and 2020 but
no overall temporal trend (see Fig. 2). Most studies (n =
19, 82%) were conducted in single countries with
Australia and the United States being the most common
with four trials (17%) each (Fig. 2). Since 2010 there has
been an increase in multi-national studies with four
identified (18%), one of which involved two countries
and the other involved six countries.
The median number of participants in the studies was
144 (range 30-3124). Of the studies reporting type of
trauma, both ‘blunt trauma’ and ‘blunt and penetrating
trauma’ were the most frequently included populations
accounting for six trials each and collectively more than
half (n = 12, 52%) of the included studies. Nine studies
did not specify whether the traumatic injury was blunt
or traumatic and two studies included minor trauma pa-
tients. Public and patient involvement was not reported
in any of the identified studies, but seven studies (all
conducted in North America) included information on
community consultation for exemption from informed
consent [19, 20, 22, 23, 31–33]. Interventions were
grouped into six broad categories: fluid therapy, anal-
gesia, blood product, temperature management, airway
management/ventilation, and model of care. These inter-
vention categories were used to group and present the
studies throughout the remainder of the review.
Participant characteristics
Participant characteristics are summarised by interven-
tion categories in Table 2. A total of 10,405 participants
were included across the 23 trials included in this re-
view. The mean age of participants in included trials was
42 years (SD 4.1) and the mean percentage of men was
60% (SD 23.4). In the three studies (13%) reporting eth-
nicity over 65% of participants were white [19, 31, 33].
Based on reported Injury Severity Scores (ISS measures
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trauma severity with a score of > 15 defining major
trauma) the mean score was 21.9 (SD 8.7).
Interventions and comparators
With regard to which interventions the RCTS were
evaluating, more than half of the studies (n = 14, 60%)
were evaluating fluid therapy or analgesia interventions
(7 trials in each category). The remaining categories
were populated as follows: blood product (n = 3),
temperature management (n = 3), airway management/
ventilation (n = 2), and model of care (n = 1) (see
Table 3). The fluid therapy category, which includes 7
trials, had the highest total number of participants at
4202, followed by the model of care category at 3124
which only included one trial. Fluid therapy interven-
tions (n = 7) were on the whole fairly homogeneous
across studies and included intravenous fluid replace-
ment protocols of various crystalloid/colloid solutions
(normal saline, hypertonic saline, and hypertonic
saline/colloid and Ringer’s lactate solution) with the
exception of one study in which the intervention was
an infusion of crystalloids and colloids. Analgesia inter-
ventions (n = 7) were heterogenous and included vari-
ous forms of pain management, such as peripheral
nerve blocks intravenous opioids or ketamine, nitrous
oxide inhalation, topical diclofenac and acupressure.
Blood product interventions included polymerised
haemoglobin or thawed plasma. Temperature manage-
ment interventions included external heating pads or
blankets or induced mild hypothermia. Airway manage-
ment and ventilation interventions included pre-
hospital intubation by paramedics and monitor-
adjusted ventilation by physicians. Only one study was
categorised as a model of care in which the intervention
evaluated dispatching a physician team in addition to a
standard response team.
Fig. 1 PRISMA diagram. RCT – Randomised controlled trial
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Table 1 Study characteristics












Fluid therapy Mortality Not reported
Kober
2001 [34]







Belgium 101 Not specified Analgesia Pain Not reported
Kober
2002 [25]
Austria 60 Minor trauma Analgesia Pain and anxiety Not reported
Helm
2003 [37]
Germany 97 Not specified Airway
management/
ventilation
PaCO2 values as a marker of




Australia 229 Blunt trauma Fluid therapy Recovery after brain injury Not reported
ID27265
2006 [26]
Germany 136 Blunt trauma Analgesia Pain Not reported
Bulger
2008 [19]
United States 209 Blunt trauma Fluid therapy Incidence of ARDS Community notification and














Recovery after brain injury Not reported
Bounes
2010 [27]
France 108 Not specified Analgesia Pain Not reported
Bulger
2010 [20]
United States and Canada 1331 Blunt trauma Fluid therapy Recovery after brain injury Community notification and







Fluid therapy Blood pressure Not reported
Bulger
2011 [22]
United States and Canada 895 Penetrating
and blunt
trauma
Fluid therapy Mortality Community notification and




Sweden 48 Blunt trauma Temperature
management
Body core temperature, cold




Australia 135 Not specified Analgesia Pain Not reported
Ducasse
2013 [29]
France 60 Not specified Analgesia Pain Not reported
Garner
2015 [39]
Australia 3124 Blunt trauma Model of care Recovery after brain injury Not reported
Schreiber
2015 [23]
United States and Canada 192 Penetrating
and blunt
trauma
Fluid therapy Early crystalloid volume;
mortality




Germany 30 Not specified Analgesia Pain Not reported
Cooper
2018 [36]
Australia, New Zealand, France,
Switzerland, Saudi Arabia and Qatar
511 Not specified Temperature
management
Recovery after brain injury Not reported
Moore
2018 [32]
United States 144 Not specified Blood product Mortality Community notification and




United States 523 Penetrating
and blunt
trauma
Blood product Mortality Community notification and
consultation were undertaken before
the study
GOSE Glasgow Outcome Scale Extended, ARDS Acute respiratory distress syndrome
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A range of comparators were evaluated in each of the
intervention categories. Few studies specified what
standard or conventional resuscitation protocols entailed
or if they varied between study centres. In intervention
categories where there was comparability between inter-
ventions (e.g. fluid therapy) often the comparators exhib-
ited greater variability. Interventions were delivered by a
range of personnel across the intervention categories
and included either paramedics only (n = 6) or advanced
life support paramedics/Emergency Medical Services
(EMS) (n = 2), intensive care paramedic (n = 1), para-
medics and other clinicians (trauma anaesthesiologists
n = 1, physicians n = 1), EMS personnel (n = 4), emer-
gency physicians (n = 4), a mix of providers (physician,
nurse and emergency medical team n = 1, and air med-
ical personnel and physicians n = 1); one study interven-
tion was delivered by a nurse in a firefighter emergency
services crew, and one by the investigator and the pa-
tient. Similarly, to the range of individuals delivering the
interventions, there was also variability in the transport
mechanism of how medical teams attended the patients
with 11 trials (48%) land-based only, eight trials land
and air medical services, and four air medical services
only. The analgesia intervention category again showing
least variability with all but one of the studies being
delivered through land-based services (See Table 3).
Trial outcomes
The primary outcomes, measures, and time-point data
from the included trials are summarised by intervention
categories in Table 4. The primary outcomes in the fluid
therapy intervention category exhibited significant het-
erogeneity, with 5 different outcomes across the 7
(largely similar) interventions being compared. These
outcomes include mortality, morbidity, recovery after
brain injury, incidence of acute respiratory distress
syndrome (ARDS), early crystalloid volume, and blood
pressure. As would be expected with this range of out-
comes measured, the associated measurement tool and
timing of outcome assessment also varied from admis-
sion to hospital, to 28 days after injury, and up to 6
months after injury. Analgesia intervention outcomes all
reported pain, but how and when this was measured
varied across studies. Studies reported the use of verbal
rating scales, visual analogue scales, binary assessments
of presence or absence of pain, or tenderness of area and
outcome assessment timing varied from 15min after
intervention to arrival at hospital. The blood product in-
terventions all measured mortality either at 28 or 30 days
after injury. Temperature management intervention out-
comes included recovery after brain injury, body core
temperature, cold discomfort and vital signs, reduced
thermal discomfort, pain, fear, and improved patient sat-
isfaction. Airway management and ventilation interven-
tion outcomes included recovery after brain injury and
arterial blood gas PaCO2 values as a marker of the ad-
equacy of ventilation. The variability in outcome selec-
tion in both the temperature management and airway
management intervention groups was mirrored in the
measurement tools and timing of outcome assessment.
The most frequently reported primary outcomes were
pain (n = 8) which was reported across 3 intervention
categories in multiple different ways and time points,
followed by mortality (n = 5) which was reported across
2 intervention categories with little variation in how and
when, and recovery after brain injury (n = 5) reported
across 4 intervention categories consistently using the
Glasgow Outcome Score (or the extended version) at 6
months after injury. The retention rate (reported as pro-
portion included in analysis) was higher in studies with
primary outcomes of interest measured during a shorter
time period.
Fig. 2 Geographical and temporal distribution of the included trials
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Methodological characteristics
The general methodological aspects of the studies were
similar across the intervention categories (see Table 5).
The included trials were generally poor at explicitly spe-
cifying the trial design with 19 (83%) not reporting the
trial design used. Of the studies that did explicitly report
design, three utilised a parallel design and one was a
cluster trial design (with clusters defined as the ‘trans-
porting base’). Given the challenges of potentially small
samples in pre-hospital trauma trials we also investigated
whether any of the included studies were adaptive de-
signs. Seven of the included studies (30%) made explicit
statements in their report that would indicate they were
adaptive designs, a further 2 were unclear, and the re-
mainder did not mention. The majority of the included
studies (n = 20) were 2 arm trials with direct head-to
head comparisons. Methods of randomisation varied
across the included trials with the use of pre-
randomised trial packs in seven of the studies, the use of
sealed envelopes in a further seven, and other options
such as telephone, toin coss or often not reported (n =
5). With regard to seeking informed consent, the major-
ity of studies (n = 12, 52%) reported the use of a waiver
of consent with consent sought for continued follow up,
prospective verbal consent was sought in 7 studies
(30%), one study reported consent was not required, and
three studies did not report the consent model. Four
studies were stopped early, two due to futility (fluid ther-
apy and blood product) and two due to insufficient en-
rolment (fluid therapy and analgesia). Risk of bias
assessment and evidence of effect are presented for each
study in Table 6. Overall, random sequence generation
was either ‘low’ or ‘unclear’ for all studies and a ‘high’
risk of bias was most frequently identified in blinding of
participants and personnel, with most reported in the
blood product and temperature management category.
Evidence of effect (i.e. benefit from intervention) was
found in 12 of the 23 studies (52%) and unclear in one
(Table 6).
Research priorities
The evidence map was compared against European re-
search priorities for pre-hospital critical care research
(which includes trauma but is restricted to physician-
provided care where as this review included trials re-
gardless of practitioner) [9]. The evidence map presented
in this review has identified randomised trials on eight
(22%) of the 36 priorities, two of which feature in the
top 5 priorities identified. These 8 priority areas include:
Pre-hospital critical care -Staffing, training and effect
(n = 1 trial identified); Advanced airway management in
pre-hospital care (n = 2 trials); Pre-hospital temperature


















(Based on 1 study reporting
data)
22.7 (9.9)
(Based on 6 studies reporting
data)
Penetrating and blunt trauma
(Based on 5 studies reporting
data)
Analgesia (n = 7) [24–30] 48.4
(13.3)
62.1% Not reported 4
(Based on 1 study reporting
data)
Blunt trauma
(Based on 1 study reporting
data)






(Based on 2 studies reporting
data)
22.7 (3.8) Penetrating and blunt trauma




56.9% Not reported 23
(Based on 1 study reporting
data)
Blunt trauma
(Based on 1 study reporting
data)
Airway management/ventilation
(n = 2) [37, 38]
38.4 (3.2) 73.1% Not reported 31.7 (1.4) Penetrating and blunt trauma
(Based on 1 study reporting
data)
Model of care (n = 1) [39] 43.5 (2.1) 73.5% Not reported 27.5 Blunt trauma
ISS Injury Severity Score, SD Standard deviation
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4202 (229) - 500 mL of intravenous crystalloids and
colloids (n = 1)
- Delayed or no infusion of
intravenous fluids
- Paramedics - Land based
services
- 250 mL intravenous infusion of 7.5%
hypertonic saline and standard intravenous
resuscitation fluids (crystalloids, Ringer’s
lactate solution or colloids) (n = 1)











- 250 mL hypertonic saline/colloid (7.5%/6%)
or hypertonic saline (7.5%) (n = 2)







- 250 mL hypertonic saline/colloid (7.5%/6%)
followed by Ringer’s lactate solution (non-
racemic, L-lactate only) (n = 1)
- Conventional resuscitation and
250mL Ringer’s lactate solution










- 250 cc normal saline and 500 cc bottle of
water (n = 1)










630 (101) - 100 mg tramadol, more if required (up to
200mg) (n = 1)






- True acupressure; points Di4 (Hegu), KS9
(Schongchong), KS6 (Neiguan), BL60
(Kunlun), and LG20 (Baihui) (n = 1)
- False or no acupressure (n = 1) - Paramedics - Land based
services
- Diclofenac-ratiopharm Gel (1, 3% or 5%) 2-
4 g twice daily (n = 1)




- Opioid titration protocol; intravenous 0.15
g/kg sufentanil followed by 0.075 g/kg
until pain relief (n = 1)
- Intravenous 0.15 mg/kg morphine






- Ketamine diluted in normal saline solution
(10 mg/mL) after initial dose of morphine
5 mg intravenously (n = 1)
- Morphine diluted in normal saline
solution (10 mg/9mL) after initial
dose of morphine 5 mg
intravenously
- Paramedics - Land based
services
- Pre-mixed 50% N2O and oxygen 9 L/min
inhalation (n = 1)
- Medical air 9 L/min for 15 min








- Single shot peripheral block proximal to
injury location under ultrasound guidance
(n = 1)
- Intravenous analgesia using
standard technique of s-ketamine











1381 (523) - Up to 6 U (50 g haemoglobin/unit) of
PolyHeme from scene of injury and during
first 12 h post-injury (n = 1)
- Crystalloids in the field and red
blood cells as needed in hospital




- Thawed plasma (n = 2) - Frozen water and normal saline
(0.9%) as per standard care (n = 1)
- Standard care resuscitation
defined by local protocol (n = 1)














659 (100) - Resistive heating; carbon-fiber electric
heating blanket set to 42 °C (n = 1)
- Passive warming - Paramedics - Land based
services
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management in critical care patients (n = 3 trials); Moni-
toring in the pre-hospital setting (n = 1 trial); Fluid
resuscitation in shock (n = 6 trials); Management of
haemorrhagic shock (n = 3 trials); Pre-hospital analgesia-
new perspectives (n = 7 trials); and Management of se-
vere head injury (n = 5 trials). The mapping review iden-
tified 22 trials that contribute evidence to answering
eight of these research priorities with some trials being
considered across more than one priority. Fourteen
(64%) of the trials, mapped to research priorities, were
published pre-2011 before identification of the research
priorities with eight (36%) published post 2011.
Although this comparison of the identified evidence and
the current priorities focuses on pre-hospital critical care
in its entirety, it highlights the dearth of randomised evi-
dence that exists for the other priorities including three
of the top five which are all directly relevant to pre-
hospital trauma care (see Table 7).
Discussion
This mapping review of the current evidence on pre-
hospital trauma trials identified 23 studies published
over the last 20 years. Of these 23 trials, 20 directly con-
tribute evidence to research priorities for prehospital
critical care (which includes major trauma but was fo-
cused on physician provided care). However, only six of
these trials were published after the development of the
prioritised list suggesting a more coordinated effort
amongst the prehospital trauma trials community to de-
velop trials that address the identified gaps in the evi-
dence base. Overall, the mapping review has shown that
there is significant heterogeneity within pre-hospital
trauma trials, specifically in terms of interventions,
comparators, and outcomes assessed. Whilst variation is
expected to some extent due to the nature of the ques-
tion driving design choices and interventions being in-
vestigated, the heterogeneity of comparators and
outcomes being assessed where interventions are similar,
creates problems for summarising intervention effects.
This mapping review has identified significant gaps in
the prehospital trauma evidence base when compared
with current overlapping research priorities and has
identified considerations for the future design and
reporting of trials in this context.
The study populations of the included studies in
this evidence map were fairly homogeneous with re-
gard to key characteristics such as age and sex (as re-
ported by included studies). Trauma and injury tends
to affect men aged 45 and under more so than other
demographic groups and our review found that the
included studies reflected this (see Table 2) [3, 4].
The ethnicity of study participants was only reported
by three studies, all of which were conducted in the
United States (with one multi-national also including
Canada), and reported the majority of participants to
be white [19, 31, 33]. The fact that only three studies
reported any data on participant ethnicity brings the
validity of the representativeness of this data for the
general trauma population into question. A 2019 sys-
tematic review of studies employing a community
consultation survey on the exception from informed
consent (EFIC), relevant for many pre-hospital trauma
trials, found that the survey respondents were not an
accurate representation of the trial population demo-
graphic with African American individuals underrep-
resented [40]. This supports the argument for further











- A heating pad reaching 50 °C applied
across anterior upper torso (n = 1)
- Polyester, woollen and rescue
blankets




- Prophylactic hypothermia by bolus of up
to 2000mL intravenous 4 °C saline (0.9%)
and surface-cooling wraps targeting core
temperature of 35 °C (n = 1)
- Normothermia; no exposure or










409 (204.5) - Monitor; ventilation adjusted to achieve
end-tidal carbon dioxide determined ac-
cording to clinical condition of each pa-
tient, ventilation determined by weight of
patients on admission (n = 1)
- Monitor-blind; ventilation set by
using a tidal-volume of 10 mL








- Pre-hospital intubation by paramedics
(n = 1)






3124 N/A - Physician team in addition to standard
response team (n = 1)




HCP Health Care Professional, EMS Emergency medical services, EMT Emergency medical technician
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consideration of ethnicity as an important factor in
trial design to ensure the study populations are truly
representative of the population which they aim to
serve. The lack of reporting of ethnicity of trial popu-
lations needs to be addressed.
Our review identified that fluid therapy and analgesia
interventions made up 60% of the included studies. Fluid
therapy interventions have been identified as a major
intervention category in a previous review covering stud-
ies published pre-2002 but analgesic interventions only
Table 4 Trial outcomes






- Mortality and morbidity
(n = 1)
- Survival (n = 1)
- Mortality – patients who died during follow up period (n = 1)
- Morbidity – postal questionnaire; Short Form with 36 items (SF-36)
(n = 1)
- Survival (n = 1)
- 28 days after






- Recovery after bran injury
(n = 2)
- Glasgow Outcome Score – Extended; 8-point scale (n = 2) - 6 months
after injury
(n = 2)
- Incidence of Acute respiratory
distress syndrome (ARDS)
(n = 1)
- Presence of ARDS; based on American-European Consensus Confer-
ence on ARDS definition
- 28 days after
injury
- Early crystalloid volume
(n = 1)
- Defined as crystalloid infused from EMS arrival until end of study
period
- 28 days after
injury











- Pain and anxiety (n = 1) - 100-mm visual analogue scale (VAS) (0 no pain or no anxiety and
100 maximum pain or maximum anxiety)
- Arrival at
hospital
- Pain (n = 1) - Verbal numerical rating (0 no pain to 10 worst pain imaginable) - Arrival at
hospital
- Pain (n = 1) - Tenderness measured by calibrated callipers in area of 1cm2 at the
centre of injured area (marked on patient’s skin), measured
between time of injury and 3 h thereafter
- 7 days after
injury










- Mortality (n = 3) - Mortality – patients who died during follow up period - 28 days after
injury (n = 1)
- 30 days after





- Recovery after brain injury
(n = 1)
- Glasgow Outcome Score – Extended; 8-point scale - 6 months
after injury
100% (N/A)
- Body core temperature, cold
discomfort and vital signs
(n = 1)
- Temperature; closed ear canal temperature sensor (Smiths Medical,
Ltd., UK)
- Cold discomfort; numerical rating scale (0 no cold to 10 unbearable
cold), very cold to hot
- Vital signs; routine EMS equipment
- Arrival at
hospital
- Improved patient satisfaction
and reduced thermal
discomfort, pain, and fear
(n = 1)
- Satisfaction; rating scale (very good to unacceptable)
- Pain; numerical rating scale (0 no pain to 5 worst imaginable pain)





- Recovery after brain injury
(n = 1)
- Glasgow Outcome Score – Extended; 8-point scale - 6 months
after injury
74.45% (N/A)
- PaCO2 values as a marker of
the adequacy of ventilation
(n = 1)




Model of care (n = 1) - Recovery after brain injury
(n = 1)
- Glasgow Outcome Score; 5-point scale - 6 months
after injury
95.6%
Björklund et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine           (2021) 29:65 Page 10 of 16
made up 12.5% of the trials identified previously [13].
Haemorrhage is the leading cause of potentially prevent-
able death in trauma patients, especially in the pre-
hospital and early stages [41]. Pre-hospital blood product
transfusion may mitigate against this. However, the com-
monly accepted standard strategies of transfusion have
been questioned [42]. Therefore, trials evaluating trans-
fusion therapy interventions have remained a strong
point of interest in pre-hospital trauma trials [43]. Yet
despite interventions being similar the heterogeneity of
outcomes in this category do not lend themselves to ag-
gregative analyses and as such contribute to research
waste. In addition, all of the interventions included in
our evidence map related to haemorrhage were non-
procedural, but there is now accumulating early evidence
of benefit from the use of procedural interventions to
treat trauma in a pre-hospital setting [44, 45]. Well de-
signed (likely adaptive), multi-national, randomised com-
parisons of these advances in complex interventions,
alongside complementary process evaluations to under-
stand key aspects of trial delivery, are essential to im-
prove the evidence base in this area.
The most common outcome reported in the in-
cluded trials was pain, reported in eight (35%) trials,
and patient-reported across a number of different
tools and at different time points. Mortality and re-
covery after brain injury were the next most com-
monly reported outcomes in the included trials, both
clinical outcomes with fairly standardised measures
and timing of assessment. Other studies have also
highlighted the heterogeneity of outcome measures in
prehospital major trauma trials and recognised the
importance of evaluating patient-centred outcomes in
this area [46]. A systematic review and patient in-
volvement exercise reported that major trauma survi-
vors consider quality of life as the most important
outcome for patients, followed by mortality or sur-
vival but this is contingent on longer term quality of
life gains [46]. The problems of outcome heterogen-
eity and a lack of inclusion of patient-relevant out-
comes in prehospital trauma trials could be addressed
through the development and use of a suite of core
outcome sets (an agreed standardised set of outcomes
that should be measured and reported, as a minimum,
in all clinical trials in specific areas of health or
health care) [47].
The lack of reported patient and public involvement in
the included trials points to the need for additional ef-
forts in this area for pre-hospital trauma trials. In
addition, the pre-hospital research prioritisation exercise
takes into account the views of clinicians only and does
not consider how those priorities might be different if
patients had also been included [9]. Involving patients in
this context can have additional challenges to some of
the healthcare contexts but that should not exclude
these important stakeholders from contributing to the











Fluid therapy (n = 7) • Not
reported
(n = 7)




• 2 (n = 6)
• 3 (n = 1)
• Pre-randomised study
packs (n = 5)
• Not reported (n = 2)
• Informed consent waived – consent
for continued follow up (n = 5)
• Not required (n = 1)
• Not reported (n = 1)












• 2 (n = 5)
• 3 (n = 1)
• 4 (n = 1)
• Toss of a coin(n = 1)
• Use of sealed opaque
envelopes (n = 3)
• Pre-randomised study
packs (n = 1)
• Not reported (n = 2)
• Informed consent waived – consent
for continued follow up (n = 1)
• Prospective verbal consent (n = 5)















• 2 (n = 3) • Service randomised
(n = 1)
• Pre-randomised study
packs (n = 1)
• Not reported (n = 1)
• Informed consent waived – consent
for continued follow up (n = 3)










• 2 (n = 3) • Use of sealed opaque
envelopes (n = 3)
• Prospective verbal consent (n = 2)
• Informed consent waived – consent












• 2 (n = 2) • Use of sealed opaque
envelopes (n = 1)
• Not reported (n = 1)
• Informed consent waived – consent
for continued follow up (n = 1)
• Not reported (n = 1)
• No early
stopping




• 2 (n = 1) • Centrally automated
system
• Informed consent waived – consent
for continued follow up (n = 1)
• No early
stopping
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research as active partners to ensure the evidence is fit
for purpose. There are notable examples of how patients
and the public are being actively involved, in prioritisa-
tion and the design and delivery of trials, in both emer-
gency research and prehospital care trials [48–50].
Learning from these exemplars is critical to ensure that
prehospital trauma trials produce evidence that is rele-
vant and accountable [48–50].
Finally, the reporting of many of these studies with re-
spect to key methodological considerations was poor
across most included trials. Whilst not assessed in detail,
even when considering what items are required to be re-
ported in the CONSORT checklist, several of the in-
cluded trials failed to report items such as: a clear
description of trial design (such as parallel, factorial);
randomisation sequence generation; and allocation
concealment [51]. Given the often small sample sizes
and requirements for responsive decision making based
on accruing data there is likely potential utility for the
use of adaptive trial designs for prehospital trauma trials.
As such, attention to the recent adaptive design CON-
SORT extension will be key for those designing adaptive
trials in this context to ensure adequate reporting [52].
Another consideration for trial design relates to the
process of seeking consent in these pre-hospital trauma
trials. Whist the majority of included trials had secured
a waiver of consent, three studies did not report on the
consent process and one stated consent was not re-
quired. Broader ethical questions and consultations with
patients about appropriate mechanisms for consent in
pre-hospital trauma trials is also required, in particular,
around clinical trials of investigational medicinal (CTIM
Table 6 Risk of bias and Evidence of effect
Green = low risk of bias, Yellow = unclear risk of bias, Red = high risk of bias
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P) trials and non-CTIMP trials where the legislation
across devolved nations in the UK is variable and as
such makes running national trials in this context
challenging.
Strengths and limitations
This review was conducted in accordance with the gen-
eral principles of the Cochrane Handbook for systematic
reviews of interventions as adapted for a mapping
review. One of the strengths of this review is the robust-
ness of the methods used through double screening at
every stage of the review process. Moreover, the search
strategy was comprehensive and covered multiple
databases.
However, there was a trade off in ensuring inclusion of
relevant studies such that we did not define ‘major trauma’
in a prehospital setting and as such two prehospital minor
trauma trials ended up being included in the review [25, 34].
Table 7 Review findings mapped against research priorities for physician-provided pre-hospital critical care
No. Suggested pre-hospital trauma research areas [9] Evidence identified in mapping review
1 Pre-hospital critical care. Staffing, training and effect ✓
2 Advanced airway management in pre-hospital care ✓
3 Define time window for time-critical interventions
4 Pre-hospital ultrasound
5 Dispatch/activation criteria for physician-manned EMS
6 Integrated information systems
7 Evaluating quality of care
8 Patient safety in the pre-hospital setting
9 Pre-hospital temperature management in critical care patients ✓
10 Monitoring in the pre-hospital setting ✓
11 Fluid resuscitation in shock ✓
12 Efficient and reliable trauma registries
13 Immobilization techniques
14 Pre-hospital management of stroke
15 Where to go with which patient?
16 Emergency cardiac care in the pre-hospital setting
17 Management of haemorrhagic shock ✓
18 Interhospital transport
19 Does further centralization give better outcomes?
20 Goal-directed therapy studies in pre-hospital critical care
21 EMS systems - regionalization of emergency care
22 Validity and impact of pre-hospital assessment
23 Economic impact of EMS
24 Pre-hospital analgesia, new perspectives ✓
25 Major incident management: How can it be improved?
26 Management of severe head injury ✓
27 Pre-hospital recognition and goal-directed therapy of sepsis
28 Paediatric transport solutions
29 Implementation of new guidelines and research findings
30 Effects of pre-hospital care on quality of life
31 Ethical implications in pre-hospital research
32 Pre-hospital care as a steering system for acute patients
33 Lay person interventions before arrival of EMS
34 Communication and interaction between EMS and hospitals
35 Evaluation of future needs in pre-hospital care
36 Pre-hospital thoracotomy
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This review limited study inclusion and studies conducted in
low-middle income countries and trials not published in
English were excluded. However, this resulted in the exclu-
sion of only four studies of which one was conducted in a
low-middle income country. Finally, the infrequent reporting
of various study aspects relating to participant characteristics,
interventions, outcomes, and study measures likely affects
the overall generalisability of the results as they may be
skewed. Risk of bias assessment especially was affected by
unclear reporting of blinding measures in many of the stud-
ies which limits the inferences that can be made regarding
the quality of the methodological aspects of the studies.
Much of these limitations can be addressed by improving
reporting of future pre-hospital trauma trials. It is important
to highlight that whilst the findings from the mapping review
were compared against an existing set of priorities for pre-
hospital research, there are some important differences be-
tween the scope of the prioritisation exercise and this review.
Namely, the prioritisation exercise considered physician only
provided care (where we included trials regardless of practi-
tioner), in prehospital critical care (which could include
trauma but is not limited to), and the aim of the prioritisa-
tion was to identify the top 5 (where as we compare our
findings across all identified priorities).
Finally, since the completion of the search in March
2020 and the publication of this review, a handful of
trials which would be eligible for inclusion have been
published. These trials have focused on interventions
targeting haemorrhage management such as tranex-
amic acid [53], fibrinogen concentrate [54], and pelvic
splinting to minimise bleeding [55]. Whilst important
trials in this field, as is they would not change the
overall findings of this mapping review. However, it
will be important to include them in any future up-
date of this review.
Conclusions
This review has successfully identified studies and
mapped the evidence for pre-hospital trauma trials pub-
lished over the last 20 years. This evidence map, when
considered alongside recent prioritisation exercises, can
lend itself as a strong basis for informing future trials in
pre-hospital trauma both in terms of what to start doing,
what to keep doing and what to do less of. Identifying
the gaps in the research, especially in their reporting and
lack of involvement of patients as partners, is important
for highlighting the areas for future research to improve
upon. Ultimately this review highlights the need (and
scope) for a paradigm shift in the design and conduct of
RCTs in this setting. There is a critical need for the de-
livery of well-designed and executed RCTs in prehospital




Database: Ovid MEDLINE(R) and Epub Ahead of
Print, In-Process & Other Non-Indexed Citations,
Daily and Versions(R) < 1946 to March 23, 2020>.
1 Emergency Medical Services/.
2 (pre-hospital or prehospital or “out of hospital” or
ambulance or paramedic? or EMS).tw,kw.
3 1 or 2.
4 exp. “Wounds and Injuries”/.
5 (trauma or wound*1 or injur* or h?emorrhag*).tw,kw.
6 4 or 5.
7 (randomized controlled trial or controlled clinical
trial).pt.
8 ((controlled or clinical or randomi#ed. or feasibility
or pilot) adj2 (trial or study)).tw,kw.
9 7 or 8.
10 3 and 6 and 9.
Database: Embase < 1974 to 2020Week 13>.
1 exp. emergency health service/.
2 (pre-hospital or prehospital or “out of hospital” or
ambulance or paramedic? or EMS).tw,kw.
3 1 or 2.
4 exp. injury/.
5 (trauma or wound*1 or injur* or h?emorrhag*).tw,kw.
6 4 or 5.
7 ((controlled or clinical or randomi#ed. or feasibility
or pilot) adj2 (trial or study)).tw,kw.
8 exp. controlled clinical trial/.
9 7 or 8.
10 3 and 6 and 9.
CENTRAL.
ID Search.
#1 MeSH descriptor: [Emergency Medical Services]
explode all trees.
#2 (pre-hospital or prehospital or “out of hospital” or
ambulance or paramedic? or EMS).
#3 #1 or #2.
#4 MeSH descriptor: [Wounds and Injuries] explode
all trees.
#5 (trauma or wound*1 or injur* or h?emorrhag*).
#6 #4 or #5.
#7 #3 and #6.
CINAHL.
S1 (MM “Emergency Medical Services+”).
S2 (MM “Emergency Medical Technicians”).
S3 TX pre-hospital or prehospital or “out of hospital”
or ambulance or paramedic? or EMS.
S4 TX s1 or s2 or s3.
S5 (MM “Trauma+”) OR (MM “Wounds and Injuries+”).
S6 TX (trauma or wound*1 or injur* or h?emorrhag*).
S7 s5 or s6.
S8 TX (controlled or clinical or randomi#ed. or feasi-
bility or pilot) N2 (trial or study).
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S9 s4 and s7 and s8.
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